Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Certain drugs that block specific enzymes can help treat prostate diseases.

Transcutol-containing vesicles improve minoxidil's skin penetration and hair growth promotion.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

Spironolactone plus finasteride reduces hirsutism more effectively.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Obese women with PCOS are more likely to have fatty liver disease.

Thyroid hormone affects skin health, with too little causing rough, pale skin and too much leading to smooth, thin skin, and may also impact wound healing and skin conditions.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Finasteride and minoxidil mix works better for hair growth than minoxidil alone, with similar safety.